Giuseppe
Emeritus
New Delhi Metallo-β-Lactamase, Ontario, Canada (Emerg Infect Dis., extract, edited)
[Source: US Centers for Disease Control and Prevention, Emerging Infectious Diseases Journal, full text: <cite cite="http://www.cdc.gov/eid/content/17/2/306.htm">New Delhi Metallo-β-Lactamase, Ontario, Canada | CDC EID</cite>. Extract, edited.]
Volume 17, Number 2?February 2011
Letter
New Delhi Metallo-β-Lactamase, Ontario, Canada
Nathalie Tijet, David C. Alexander, David Richardson, Olga Lastovetska, Donald E. Low, Samir N. Patel, and Roberto G. Melano
Author affiliations: Ontario Agency for Health Protection and Promotion, Toronto, Ontario, Canada (N. Tijet, D.C. Alexander, O. Lastovetska, D.E. Low, S.N. Patel, R.G. Melano); University of Toronto, Toronto (D.C. Alexander, O. Lastovetska, D.E. Low, S.N. Patel); William Osler Health Centre, Brampton Civic Hospital, Brampton, Ontario, Canada (D. Richardson); and Mount Sinai Hospital, Toronto (D.E. Low, R.G. Melano)
To the Editor:
The New Delhi metallo-β-lactamase (NDM-1) was first characterized in 2009 from Klebsiella pneumoniae and Escherichia coli isolated from a patient in Sweden who had received medical care in New Delhi, India (1). Further studies have shown broad dissemination of this β-lactamase gene (blaNDM-1) in India, Pakistan, Bangladesh, and the United Kingdom (2). Additional isolates have been detected in other countries, and many of the patients with NDM-1?producing Enterobacteriaceae reported receiving medical care in the Indian subcontinent (1?7). We describe detection and characterization of an NDM-1?producing K. pneumoniae isolated in Ontario, Canada.
(...)
-
------
[Source: US Centers for Disease Control and Prevention, Emerging Infectious Diseases Journal, full text: <cite cite="http://www.cdc.gov/eid/content/17/2/306.htm">New Delhi Metallo-β-Lactamase, Ontario, Canada | CDC EID</cite>. Extract, edited.]
Volume 17, Number 2?February 2011
Letter
New Delhi Metallo-β-Lactamase, Ontario, Canada
Nathalie Tijet, David C. Alexander, David Richardson, Olga Lastovetska, Donald E. Low, Samir N. Patel, and Roberto G. Melano
Author affiliations: Ontario Agency for Health Protection and Promotion, Toronto, Ontario, Canada (N. Tijet, D.C. Alexander, O. Lastovetska, D.E. Low, S.N. Patel, R.G. Melano); University of Toronto, Toronto (D.C. Alexander, O. Lastovetska, D.E. Low, S.N. Patel); William Osler Health Centre, Brampton Civic Hospital, Brampton, Ontario, Canada (D. Richardson); and Mount Sinai Hospital, Toronto (D.E. Low, R.G. Melano)
To the Editor:
The New Delhi metallo-β-lactamase (NDM-1) was first characterized in 2009 from Klebsiella pneumoniae and Escherichia coli isolated from a patient in Sweden who had received medical care in New Delhi, India (1). Further studies have shown broad dissemination of this β-lactamase gene (blaNDM-1) in India, Pakistan, Bangladesh, and the United Kingdom (2). Additional isolates have been detected in other countries, and many of the patients with NDM-1?producing Enterobacteriaceae reported receiving medical care in the Indian subcontinent (1?7). We describe detection and characterization of an NDM-1?producing K. pneumoniae isolated in Ontario, Canada.
(...)
-
------